Active
constituents
The kava-lactones, sometimes
referred to as kava-pyrones, are the most
important active constituents in kava extracts.
High-quality kava rhizome contains 5.5–8.3%
kava-lactones. Medicinal extracts used in Europe
contain 30–70% kava-lactones. Kava-lactones are
thought to have anti-anxiety, mild analgesic
(pain-relieving), muscle-relaxing, and
anticonvulsant effects. Some researchers
speculate that kava may directly influence the
limbic system, the ancient part of the brain
associated with emotions and other brain
activities.4 Kava is a unique
anti-anxiety alternative because it does not
seem to impair reaction time or alertness when
used in the amounts recommended
below.
Kava
has been extensively studied as a treatment for
anxiety. The amount often used in
clinical trials is 100 mg of an extract
(standardized to 70% kava-lactones) three times
per day. Double-blind trials, including one that
lasted six months, have shown that kava
effectively reduces symptoms of anxiety in
people with mild to moderate anxiety. One trial
found that kava also reduced symptoms of anxiety
in menopausal women, and in another study kava
enhanced the anti-anxiety effect of hormone
replacement therapy. One trial
found kava to be just as effective as
benzodiazepines
(a common class of drugs prescribed for anxiety)
in treating mild anxiety over the course of six
weeks.
Are there any side
effects or interactions?
In November 2001, German
authorities announced that 24 cases of liver
disease (including hepatitis, liver failure, and
cirrhosis) associated with the use of kava had
been reported in Germany; of these, one person
died and three required a liver
transplant.14
Prior
to this report, it had been widely believed that
kava did not cause any serious side effects. The
1998 edition of the German Commission E
Monographs, considered to be an
authoritative source on herbal medicines, does
not mention liver disease in its discussion of
kava’s side effects. Since that time, four case
reports of kava-related liver toxicity have
appeared in medical journals. In two of these
cases, severe liver failure resulted in the need
for a liver transplant. Most, though not all, of
the individuals who developed liver damage while
taking kava were also taking at least one other
medication that has been associated with liver
injury. That raises the possibility that these
other drugs, rather than kava, may have been
responsible for the problem in some cases. It is
also conceivable that kava interacts with some
of these drugs, thereby increasing their
toxicity. However, some of the cases of
kava-related liver disease cannot be explained
by the concomitant use of other
drugs.
The
possibility that kava can cause liver damage is
supported by a survey of an Aboriginal community
in Australia. Although occasional users of kava
in this community generally had normal liver
function, laboratory evidence of liver injury
was quite common among heavy users of the herb.
Furthermore, the risk of liver damage was
directly related to the amount of kava consumed.
It is not clear how relevant these findings are
to other communities, since the overall health
of the Aborigines who were studied was
relatively poor.
It is
also unclear whether kava is safe when taken in
“normal” amounts. A recent survey of 400 German
medical practices revealed that 78% of the kava
prescriptions that were written significantly
exceeded the recommended amount. However, some
of the 24 patients reported to German
authorities were not exceeding the
manufacturer’s recommended level of intake when
they developed liver disease. In addition, in
two of the four published case reports, the
amount of kava used was equal to or only
slightly higher than the manufacturer’s
recommendation. Therefore, one cannot assume
that the recommended level of intake of kava is
safe for all individuals.
Health authorities worldwide are
considering or implementing a ban on kava. Until
additional information clarifies the extent of
the risk involved, it is strongly recommended
that all individuals consult their physician
before taking kava. In addition, based on the
available information, it seems that people with
liver disease and those taking medications that
have the potential to damage the liver should
not take kava.
In
recommended amounts, the most common side effect
from kava use is mild gastrointestinal
disturbances in some people. Kava may
temporarily turn the skin yellow, according to
some case studies. If this occurs, people should
discontinue kava use. In rare cases, an allergic
skin reaction, such as a rash, may occur.
Enlargement of the pupils has also been reported
after long-term use of kava. In the amounts
discussed above, kava does not appear to be
addictive.
Kava
is not recommended for use by pregnant or
breast-feeding women. It should not be taken
together with other substances that also act on
the central nervous system, such as alcohol,
barbiturates, antidepressants, and antipsychotic drugs.
One study found that large amounts of a
traditional kava preparation did worsen
cognitive impairment caused by alcohol
consumption. However, at the amounts recommended
above, kava does not appear to impair cognitive
performance. Kava has also been reported to
cause excessive sedation and grogginess when
combined with benzodiazepines.
One study found it was safe to drive after
taking kava at the amounts listed above.
However, the German Commission E monograph
states that kava, when taken at the recommended
levels, may adversely affect a person’s ability
to safely drive or operate heavy
machinery.
Caution: Aside
from the reported interactions, kava inhibits a
number of the cytochrome P450 enzymes that play
a role in the breakdown of many medications.
Therefore, kava has the potential to interact
with a wide range of medications, even if such
interactions have not yet been reported.
Individuals taking any medication who wish to
use kava should check with their physician or
pharmacist to determine whether inhibiting
cytochrome P450 could cause an adverse drug
interaction.
Are there
any drug interactions?
Certain
medicines may interact with
kava.